The discussion will focus on how the remarkable confluence of theory and reality will pay real dividends for Biotech/Life Science ventures now and in the coming years. Some of the topics planned to be discussed are as follows:

• The Global Outlook for Biotech & Life Science Investments
• What VC's are looking for in Biotechnology/Life Science ventures
• How technology will change the future of medicine (information based medicines)
• Real-life winning strategies for Biotech/Life Science companies
• Biotech and Life Science in the New York Tristate Area
• Early stage funding issues for Biotech and Life Science ventures
• Implications of strategic partnerships with big Pharma companies
• How to choose venture caplitalists as partners beyond money
• How to value a Biotech venture
• Hiring and compensation of Biotech executives
• Exit strategy - M&A and IPO environments
• Incentives, tax subsidies, labor laws, and scientific pools for Biotech companies around the world
• Genomic mapping and its implications for the future of biotechnology ventures
• Speciality Pharma and Big Pharma - The Future
• Devices & Drugs
• Personalized medicine and the future
• The confluence of Nanotechnology and Biotech/Life Science and new opportunities

_____________________________

Program schedule, date, location and speakers are subject to change